SELINEXOR for Dedifferentiated liposarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where SELINEXOR was used for Dedifferentiated liposarcoma.
Most Reported Side Effects for SELINEXOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 2,372 | 31.8% | 280 | 559 |
| Fatigue | 1,795 | 24.1% | 195 | 424 |
| Decreased appetite | 1,290 | 17.3% | 169 | 348 |
| Diarrhoea | 1,190 | 16.0% | 151 | 344 |
| Plasma cell myeloma | 1,046 | 14.0% | 202 | 220 |
| Vomiting | 860 | 11.5% | 107 | 243 |
| Asthenia | 794 | 10.7% | 100 | 267 |
| Death | 761 | 10.2% | 756 | 203 |
| Thrombocytopenia | 692 | 9.3% | 125 | 202 |
| Platelet count decreased | 610 | 8.2% | 83 | 210 |
| Weight decreased | 599 | 8.0% | 80 | 147 |
| Pneumonia | 422 | 5.7% | 126 | 343 |
| Anaemia | 420 | 5.6% | 83 | 177 |
| Dizziness | 412 | 5.5% | 33 | 98 |
| Off label use | 412 | 5.5% | 64 | 85 |
Other Indications for SELINEXOR
Plasma cell myeloma (5,659)
Product used for unknown indication (380)
Diffuse large b-cell lymphoma (373)
Plasma cell myeloma refractory (165)
Brain neoplasm malignant (136)
Acute myeloid leukaemia (60)
Glioblastoma (54)
Malignant neoplasm of unknown primary site (30)
Plasma cell myeloma recurrent (28)
Neoplasm malignant (26)
Other Drugs Used for Dedifferentiated liposarcoma
DOXORUBICIN (40)
TRABECTEDIN (28)
IFOSFAMIDE (24)
PALBOCICLIB (23)
ERIBULIN (16)
GEMCITABINE (13)
UNSPECIFIED INGREDIENT (11)
NIVOLUMAB (9)
DOCETAXEL (7)
INVESTIGATIONAL PRODUCT (6)